Definition And Mechanism
- Prosthetic device designed to bypass injured organ of Corti.
- Directly stimulates residual cochlear nerve cells located within spiral ganglion.
- Converts environmental auditory stimuli into digital radiofrequency impulses.
- Replaces normal physiologic transmission involving hair cell sound vibration, ion release, and neurotransmitter activation.
Device Components
- System combines externally worn and surgically implanted internal components.
| Component Category | Specific Parts | Functional Role |
|---|---|---|
| External | Microphone | Detects environmental sounds. |
| External | Speech processor | Minicomputer digitizes and codes input signal using proprietary speech processing strategies. |
| External | Transmitter coil | Relays coded signals across skin via frequency modulation signal. |
| Internal | Receiver | Converts transmitted radiofrequency codes into electrical impulses. |
| Internal | Electrode array | Creates electrical fields acting directly on cochlear nerve. |
Indications And Candidacy
- Indicated for bilateral severe to profound sensorineural hearing loss exceeding 70 decibels.
- Requires documented unsatisfactory benefit from conventional hearing aids after 3 to 6 month trial.
- Minimum age approved by United States Food and Drug Administration reduced to 9 months.
- Off-label utilization demonstrates efficacy in younger infants and children retaining residual hearing.
- Early intervention before 2 years of age optimizes outcomes, enabling over 90 percent of children to enter mainstream education.
Preoperative Evaluation
- Requires comprehensive audiologic testing to establish baseline deficits.
- High-resolution computed tomography assesses bony temporal bone and inner ear anatomy.
- Magnetic resonance imaging confirms presence and structural integrity of cochlear nerve.
Surgical Management
- Procedure performed under general anesthesia.
- Involves mastoidectomy coupled with widening of facial recess to access inner ear.
- Internal stimulator package fastened securely within mastoid process.
- Cochlea opened typically via round window to insert multielectrode array into scala tympani.
- Extreme caution exercised to prevent cochlear fluid contamination by bone dust or blood.
- Intraoperative audiologist testing immediately verifies device functional integrity via cranial nerve VIII electrophysiologic responses.
- Intraoperative plain radiograph confirms precise electrode array placement.
Postoperative Rehabilitation
- Initial healing period spans 3 to 4 weeks, during which child remains without auditory input.
- Initial stimulation establishes baseline programming for first sound access.
- Program modification relies on behavioral testing and observed vocalization changes.
- Demands intensive, long-term commitment to speech and language therapy.
- Bilateral implantation preferred over unilateral procedure to improve sound localization and speech understanding in noisy environments.
Complications And Special Considerations
| Complication/Issue | Clinical Management And Prevention |
|---|---|
| Pneumococcal meningitis | Represents severe potential complication. Strict mandate requires pneumococcal polyvalent vaccine (PCV13) administration prior to surgery. |
| Acute mastoiditis | Occurs in 3.5 percent of implanted children. Successfully managed with intravenous antibiotics, tympanostomy tubes, and abscess drainage without requiring implant removal. |
| Magnetic resonance imaging incompatibility | Strong magnetic fields risk implant damage. Most modern implants verified safe only for scanners up to 3.0 Tesla. |